Clinical trial
A Randomized, Evaluator-blind, Matched Pairs, Prospective, Non Inferiority, Confirmatory Study to Compare the Safety and Efficacy Between Lafullen15 and Lafullen in the Correction of Nasolabial Folds
NCT06295172 is registered in ClinicalTrials.gov with Samyang Biopharmaceuticals Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Evaluator-blind, Matched Pairs, Prospective, Non Inferiority, Confirmatory Study to Compare the Safety and Efficacy Between Lafullen15 and Lafullen in the Correction of Nasolabial Folds
- Lead sponsor
- Samyang Biopharmaceuticals Corporation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 27, 2024
- Completion date
- April 30, 2026
- Enrollment
- 73 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial folds